Not Yet Recruiting PHASE1 INTERVENTIONAL 4-arm
NCT06648876
PK and PD of YG1699 in CKD Patients With Diabetes
Pharmacokinetic and Pharmacodynamics of YG1699 in Patients With Diabetes and Kidney Dysfunction
Sponsor: RenJi Hospital
Conditions
Diabetes Hemodialysis Renal Insufficiency, Chronic
Updated 1 time since 2024 Last updated: Oct 17, 2024 Started: Oct 31, 2024 Primary completion: Aug 31, 2025 Completion: Oct 30, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE1 trial investigates Diabetes and Hemodialysis and is currently actively recruiting participants. RenJi Hospital leads this study, which shows 1 recorded version since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- RenJi Hospital
Data source: RenJi Hospital
For direct contact, visit the study record on ClinicalTrials.gov .